NCT05963724 (CAD) is a NA clinical trial of Real-Time Computer Aided Detection in Colorectal Cancer, sponsored by Riverside University Health System Medical Center.

Who is sponsoring NCT05963724?

NCT05963724 is sponsored by Riverside University Health System Medical Center.

What drugs are being tested in NCT05963724?

Interventions in NCT05963724: Real-Time Computer Aided Detection, Stanford Colonoscopy.

What condition does NCT05963724 study?

NCT05963724 studies Colorectal Cancer, Colorectal Neoplasms.

Is NCT05963724 still recruiting?

NCT05963724 is currently completed. Last updated 27 July 2023.

Last reviewed 2023-07-27 · How we verify

NCT05963724: CAD

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Real-Time CAD for Colonic Neoplasia: A RCT

Completed NA Last updated 27 July 2023

What this trial tests

NA trial testing Real-Time Computer Aided Detection in Colorectal Cancer in 1,100 participants. Completed in 27 May 2023.

Timeline

1 September 2022

Primary endpoint
31 March 2023

27 May 2023

Quick facts

Lead sponsor	Riverside University Health System Medical Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	screening
Enrollment	1,100
Start date	1 September 2022
Primary completion	31 March 2023
Estimated completion	27 May 2023
Sites	1 location across United States

Drugs / interventions tested

Real-Time Computer Aided Detection
Stanford Colonoscopy

Conditions studied

Colorectal Cancer — all drugs for Colorectal Cancer →
Colorectal Neoplasms — all drugs for Colorectal Neoplasms →

Sponsor

Riverside University Health System Medical Center

Who can join

Adults 30 to 100, any sex, with Colorectal Cancer or Colorectal Neoplasms. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study assesses the sensitivity and added benefits of computer-aided detection compared to standard care (white-light) in detecting colon polyps in patients undergoing colonoscopy.

Publications & conference data

3 peer-reviewed publications reference this trial (live from Europe PMC):

The Efficacy of Real-time Computer-aided Detection of Colonic Neoplasia in Community Practice: A Pragmatic Randomized Controlled Trial.
Thiruvengadam NR, Solaimani P, Shrestha M, Buller S, et al · · 2024 · cited 17× · PMID 38437999 · DOI 10.1016/j.cgh.2024.02.021
Artificial Intelligence for the Diagnosis and Management of Cancers: Potentials and Challenges.
Wang M, Chang W, Zhang Y. · · 2025 · cited 1× · PMID 41200279 · DOI 10.1002/mco2.70460
Artificial Intelligence in Oncology: A 10-Year ClinicalTrials.gov-Based Analysis Across the Cancer Control Continuum.
Verma H, Mistry S, Jayam KV, Shrestha P, et al · · 2025 · PMID 41228330 · DOI 10.3390/cancers17213537

Verify or expand the search:

Other recruiting trials for Colorectal Cancer

Currently open trials in the same condition.

NCT07152821 — Botensilimab + Balstilimab vs Best Supportive Care as Therapy in Chemo-refractory, Unresectable, Colorectal Adenocarcino · Phase 3 · recruiting
NCT07353645 — KRAS Neoantigen Nanovaccine as Adjuvant Therapy for Colorectal Cancer/Pancreatic Cancer · Phase 1, PHASE2 · recruiting
NCT07432633 — [18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications · Phase 1, PHASE2 · recruiting
NCT07523919 — Functional and Respiratory Determinants of Long-Term Colorectal Cancer Outcomes · recruiting
NCT07529301 — Functional and Respiratory Predictors of Early Postoperative Outcomes · recruiting

Other Riverside University Health System Medical Center trials

Trials by the same sponsor.

NCT06844201 — Postoperative Delirium After Intraoperative Ephedrine Versus Norepinephrine · not yet recruiting
NCT06816355 — Exogenous Sex Hormones and PONV · completed
NCT06805435 — Is Continuous Non-Invasive Monitoring Accurate When Used on the Lower Extremity: Finger Vs Toe? · completed
NCT07221370 — Enteral Vancomycin as Primary Prophylaxis Against Clostridioides Difficile Infection in Critically Ill Patients · Phase 2, PHASE3 · recruiting
NCT04436718 — Does Ultrasound Assessment for Extravascular Lung Water and IVC Measurement Affect Outcomes in Inpatient Heart Failure M · NA · unknown

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05963724 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Riverside University Health System Medical Center
Last refreshed: 27 July 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05963724.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing